Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression
A study of L-DOPA for Depression and Slowing in Older Adults
Sponsor: NIMH
Enrolling: Male and Female Patients
Study Length: 3 Weeks
IRB Number: 7270
U.S. Govt. ID: NCT02744391
Contact: Veronika Bailey: 646-774-8655 / vbailey@nyspi.columbia.edu
Additional Study Information: In this research study, you will receive a medication called carbidopa/levodopa (Sinemet). This medication is approved by the Food and Drug Administration for the treatment of Parkinson's Disease. We are using carbidopa/levodopa off-label in this study to see whether it is capable of improving depressive symptoms as well as mental and physical slowing that occur as people age.
This study is closed
Investigator
Do You Qualify?
Have you ever been diagnosed with Bipolar Disorder (or manic-depressive illness)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Veronika Bailey
vbailey@nyspi.columbia.edu
646-774-8655
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE